Environmental biotechnology is the branch of biotechnology that addresses environmental problems, such as the removal of pollution, renewable energy generation or biomass production, by exploiting ...
The Zenless Zone Zero 1.5 release date is Wednesday, January 22, 2025. This update is expected to go live at 7pm PT / 10pm ET / 3am GMT / 4am CET / 2pm AEDT. ZZZ’s servers go offline for ...
Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...
A B Corps company, Chiesi’s LEED Platinum certified Biotech Centre of Excellence will focus mainly on rare disease biologics – another shift in the family-business pharma’s image and action.
“From Ground Zero” is a rare work for which superlatives are not only inadequate but useless. It’s an anthology of 22 short subject by Palestinians living in the Israeli-occupied Gaza Strip. Most are ...
Regeneron, maker of the blockbuster ophthalmology medicine Eylea, has acquired an ocular biotech, the large biopharma confirmed to Endpoints News on Thursday.
No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...
2024 was the year of the private megaround. Nine-figure financings dominated biotech’s venture funding landscape, with 96 such rounds tallied by Endpoints News. The bevy … ...
Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...
A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...
The predictive design of gene circuits in plants has been challenging and lagging behind other organisms. Here, the authors report a predictive framework for designing synthetic genetic circuits ...